Adamis Pharma files U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED - Seeking Alpha

Adamis Pharma files U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED - Seeking Alpha | "marketing" - Google News | December 31, 2018 at 09:00AM
Adamis Pharma files U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED  Seeking Alpha

Adamis Pharmaceuticals (ADMP) has filed an NDA with the FDA seeking approval for its fast-dissolving sublingual tadalafil tablet for the treatment of erect.

December 31, 2018 at 09:00AM | "marketing" - Google News
Adamis Pharma files U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED - Seeking Alpha
"marketing" - Google News